和誉-B(02256):和誉医药将在2025年ESMO GI会议汇报依帕戈替尼与阿替利珠单抗联用治疗晚期肝细胞癌的最新2期临床试验数据
Last Update:
13 5 月, 2025
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.